RNA Therapy Market Size, Share, Growth, and Industry Analysis, By Types (RNA Interference (RNAi), RNA Antisense, ), By Applications (Genetic Disorders, Auto immune disorders, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global RNA Therapy Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 RNA Therapy Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 RNA Therapy Business Mode and Production Process

2.3.1 RNA Therapy Business Mode Analysis

2.3.2 Production Process Analysis

2.4 RNA Therapy Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of RNA Therapy

2.4.2 Raw Material Cost of RNA Therapy

2.4.3 Labor Cost of RNA Therapy

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global RNA Therapy Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global RNA Therapy Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global RNA Therapy Price by Manufacturer (2021-2026)

4.4 RNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of RNA Therapy, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of RNA Therapy, Product Offered and Application

4.7 RNA Therapy Market Competitive Situation and Trends

4.7.1 RNA Therapy Market Concentration Rate

4.7.2 Global Top 3 and Top 6 RNA Therapy Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global RNA Therapy Market Historical Development by Geographic Region (2021-2026)

5.1 Global RNA Therapy Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global RNA Therapy Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America RNA Therapy Market Status by Country (2021-2026)

5.3.1 North America RNA Therapy Sales Volume by Country (2021-2026)

5.3.2 North America RNA Therapy Revenue by Country (2021-2026)

5.3.3 United States RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe RNA Therapy Market Status by Country (2021-2026)

5.4.1 Europe RNA Therapy Sales Volume by Country (2021-2026)

5.4.2 Europe RNA Therapy Revenue by Country (2021-2026)

5.4.3 Germany RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific RNA Therapy Market Status by Country (2021-2026)

5.5.1 Asia Pacific RNA Therapy Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific RNA Therapy Revenue by Country (2021-2026)

5.5.3 China RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America RNA Therapy Market Status by Country (2021-2026)

5.6.1 Latin America RNA Therapy Sales Volume by Country (2021-2026)

5.6.2 Latin America RNA Therapy Revenue by Country (2021-2026)

5.6.3 Mexico RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa RNA Therapy Market Status by Country (2021-2026)

5.7.1 Middle East and Africa RNA Therapy Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa RNA Therapy Revenue by Country (2021-2026)

5.7.3 GCC RNA Therapy Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa RNA Therapy Sales Volume, Revenue and Growth (2021-2026)



6 Global RNA Therapy Market Historical Development by Product Type (2021-2026)

6.1 RNA Therapy Definition by Type

6.2 Global RNA Therapy Historical Sales Volume by Product Type (2021-2026)

6.3 Global RNA Therapy Historical Revenue by Product Type (2021-2026)

6.4 Global RNA Therapy Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global RNA Therapy Historical Sales Volume, Revenue and Growth Rate of RNA Interference (RNAi) (2021-2026)
6.5.2 Global RNA Therapy Historical Sales Volume, Revenue and Growth Rate of RNA Antisense (2021-2026)


7 Global RNA Therapy Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global RNA Therapy Historical Sales Volume by End User (2021-2026)

7.3 Global RNA Therapy Historical Revenue by End User (2021-2026)

7.4 Global RNA Therapy Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global RNA Therapy Historical Sales Volume, Revenue and Growth Rate of Genetic Disorders (2021-2026)
7.5.2 Global RNA Therapy Historical Sales Volume, Revenue and Growth Rate of Auto immune disorders (2021-2026)


8 Leading Companies Profiles

8.1 Benitec Biopharma Inc.
8.1.1 Benitec Biopharma Inc. Corporation Information
8.1.2 Benitec Biopharma Inc. - RNA Therapy Product Portfolio and Specification
8.1.3 Benitec Biopharma Inc. Performance Analysis (2021-2026)
8.1.4 Benitec Biopharma Inc. Business and Markets Served
8.1.5 Benitec Biopharma Inc. Recent Developments
8.2 Alnylam Pharmaceuticals, Inc.
8.2.1 Alnylam Pharmaceuticals, Inc. Corporation Information
8.2.2 Alnylam Pharmaceuticals, Inc. - RNA Therapy Product Portfolio and Specification
8.2.3 Alnylam Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.2.4 Alnylam Pharmaceuticals, Inc. Business and Markets Served
8.2.5 Alnylam Pharmaceuticals, Inc. Recent Developments
8.3 Ionis Pharmaceuticals
8.3.1 Ionis Pharmaceuticals Corporation Information
8.3.2 Ionis Pharmaceuticals - RNA Therapy Product Portfolio and Specification
8.3.3 Ionis Pharmaceuticals Performance Analysis (2021-2026)
8.3.4 Ionis Pharmaceuticals Business and Markets Served
8.3.5 Ionis Pharmaceuticals Recent Developments
8.4 Arrowhead Pharmaceuticals
8.4.1 Arrowhead Pharmaceuticals Corporation Information
8.4.2 Arrowhead Pharmaceuticals - RNA Therapy Product Portfolio and Specification
8.4.3 Arrowhead Pharmaceuticals Performance Analysis (2021-2026)
8.4.4 Arrowhead Pharmaceuticals Business and Markets Served
8.4.5 Arrowhead Pharmaceuticals Recent Developments
8.5 Biogen, Inc
8.5.1 Biogen, Inc Corporation Information
8.5.2 Biogen, Inc - RNA Therapy Product Portfolio and Specification
8.5.3 Biogen, Inc Performance Analysis (2021-2026)
8.5.4 Biogen, Inc Business and Markets Served
8.5.5 Biogen, Inc Recent Developments
8.6 Genzyme (Sanofi)
8.6.1 Genzyme (Sanofi) Corporation Information
8.6.2 Genzyme (Sanofi) - RNA Therapy Product Portfolio and Specification
8.6.3 Genzyme (Sanofi) Performance Analysis (2021-2026)
8.6.4 Genzyme (Sanofi) Business and Markets Served
8.6.5 Genzyme (Sanofi) Recent Developments
8.7 Sarepta Therapeutics
8.7.1 Sarepta Therapeutics Corporation Information
8.7.2 Sarepta Therapeutics - RNA Therapy Product Portfolio and Specification
8.7.3 Sarepta Therapeutics Performance Analysis (2021-2026)
8.7.4 Sarepta Therapeutics Business and Markets Served
8.7.5 Sarepta Therapeutics Recent Developments
8.8 Silence Therapeutics plc
8.8.1 Silence Therapeutics plc Corporation Information
8.8.2 Silence Therapeutics plc - RNA Therapy Product Portfolio and Specification
8.8.3 Silence Therapeutics plc Performance Analysis (2021-2026)
8.8.4 Silence Therapeutics plc Business and Markets Served
8.8.5 Silence Therapeutics plc Recent Developments
8.9 Gradalis, Inc.
8.9.1 Gradalis, Inc. Corporation Information
8.9.2 Gradalis, Inc. - RNA Therapy Product Portfolio and Specification
8.9.3 Gradalis, Inc. Performance Analysis (2021-2026)
8.9.4 Gradalis, Inc. Business and Markets Served
8.9.5 Gradalis, Inc. Recent Developments
8.10 Arbutus Biopharma Corporation
8.10.1 Arbutus Biopharma Corporation Corporation Information
8.10.2 Arbutus Biopharma Corporation - RNA Therapy Product Portfolio and Specification
8.10.3 Arbutus Biopharma Corporation Performance Analysis (2021-2026)
8.10.4 Arbutus Biopharma Corporation Business and Markets Served
8.10.5 Arbutus Biopharma Corporation Recent Developments


9 Global RNA Therapy Market Forecast by Product Type and End User (2026-2034)

9.1 Global RNA Therapy Market Forecast by Product Type (2026-2034)

9.1.1 Global RNA Therapy Sales Volume, Revenue Forecast and Growth Rate of RNA Interference (RNAi) (2026-2034)
9.1.2 Global RNA Therapy Sales Volume, Revenue Forecast and Growth Rate of RNA Antisense (2026-2034)
9.2 Global RNA Therapy Market Forecast by End User (2026-2034)

9.2.1 Global RNA Therapy Sales Volume, Revenue Forecast and Growth Rate of Genetic Disorders (2026-2034)
9.2.2 Global RNA Therapy Sales Volume, Revenue Forecast and Growth Rate of Auto immune disorders (2026-2034)


10 Global RNA Therapy Market Forecast by Geographic Region (2026-2034)

10.1 Global RNA Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa RNA Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer